Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Bioavailability of SC vs IV Furosemide in Heart Failure
NCT02329834Phase 3Completed
- Sponsor
- scPharmaceuticals Inc.
- Start
- Apr 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of furosemide in heart failure (HF) (2 arms), sponsored by scPharmaceuticals Inc. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration and 7 more. Started Apr 2015; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02329834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329834.